Clinical significance of ROS1 5' deletions in non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Lung cancer"
DOI: 10.1016/j.lungcan.2019.07.017
Abstract: OBJECTIVES Patients harboring rearrangements of the ROS1 gene are eligible for first-line therapy with Crizotinib, which represents the best available treatment option. Diagnostic criteria, based on break-apart fluorescence in situ hybridization, were mirrored from ALK… read more here.
Keywords: crizotinib; fusion; lung cancer; ros1 ... See more keywords